Associated Papers
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals.
Wang LY et al.
Innovation (cambridge (mass.)), 2025
39991480 (PubMed )
Supplement: mmc5.xlsx › Sheet1
Use of Germline Genetic Variability for Prediction of Chemoresistance and Prognosis of Breast Cancer Patients.
Hlavac V et al.
Cancers, 2018
Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy.
Limviphuvadh V et al.
Bmc Cancer, 2018
29751792 (PubMed )
Supplement: 12885_2018_4471_MOESM1_ESM.zip › TableS2R2.xlsx › Table_S2
Genetic variants in cellular transport do not affect mesalamine response in ulcerative colitis.
Moran CJ et al.
Plos One, 2018
Development of a novel, fully-automated genotyping system: principle and applications.
Suzuki S et al.
Sensors (basel, Switzerland), 2012
Single and combined IL28B, ITPA and SLC28A3 host genetic markers modulating response to anti-hepatitis C therapy.
Lötsch J et al.
Pharmacogenomics, 2011
Role of nucleoside transporters SLC28A2/3 and SLC29A1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis C.
Doehring A et al.
Pharmacogenetics and Genomics, 2011
Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3).
Badagnani I et al.
The Pharmacogenomics Journal, 2005
Gemcitabine and platinum pathway pharmacogenetics in Asian breast cancer patients.
Wong AL et al.
Cancer Genomics & Proteomics, 0
Select a paper to view details